What serious gut side effects can GLP-1 medications cause?

The main serious concerns include acute pancreatitis, gallbladder disease, bowel obstruction, gastroparesis (stomach paralysis), and severe constipation. However, these events are relatively uncommon.

Should stomach side effects influence which diabetes medication I choose?

Based on this study, serious gut side effects appear similar across dulaglutide, semaglutide, and tirzepatide. Talk to your doctor about other factors like blood sugar goals, weight loss, cost, and dosing convenience.

How large was this study and can I trust the results?

This was a very large study covering over 130,000 matched patients from real clinical practice between 2019 and 2024, making the findings highly relevant to everyday patients. It was published in the respected Annals of Internal Medicine.

Ozempic vs Mounjaro vs Trulicity: Gut Side Effects Compared

Key takeaways

✓All three medications showed similar rates of serious gut complications in over 130,000 real-world patients
✓No single drug stood out as significantly more dangerous for stomach or intestinal problems
✓Findings help patients and doctors choose between these medications based on other factors like cost and effectiveness

Quick specs

Journal	Annals of internal medicine
Year	2026
PMID	41183330

What This Study Looked At

Researchers wanted to know whether popular type 2 diabetes and weight-loss medications — dulaglutide (Trulicity), semaglutide (Ozempic), and tirzepatide (Mounjaro) — differed in their risk of causing serious gastrointestinal (stomach and gut) problems.

How the Study Was Done

Scientists studied real-world medical records of over 130,000 adults with type 2 diabetes who started one of these three medications between 2019 and 2024. They carefully matched patients so the groups were as similar as possible, then tracked who experienced serious gut complications.

What Serious Side Effects Were Tracked?

The researchers looked at five serious conditions:

Acute pancreatitis – sudden painful inflammation of the pancreas
Biliary disease – gallbladder and bile duct problems
Bowel obstruction – dangerous blockage in the intestines
Gastroparesis – stomach paralysis causing slow digestion
Severe constipation – serious difficulty passing stools

What Did They Find?

The key finding was reassuring: all three medications showed very similar rates of serious gut complications. None of the drugs stood out as significantly safer or more dangerous than the others when it came to these serious events.

In numbers, the hazard ratios (a measure of risk comparison) were all close to 1.0, meaning no meaningful difference:

Semaglutide vs. dulaglutide: 0.96 (essentially the same)
Tirzepatide vs. dulaglutide: 0.96 (essentially the same)
Tirzepatide vs. semaglutide: 1.07 (essentially the same)

What Does This Mean for You?

If you and your doctor are deciding between these medications, this study suggests that serious stomach and gut safety should not be the deciding factor — they appear equally safe in that regard. Other considerations like cost, how often you inject, weight loss goals, and blood sugar control may be more important in choosing between them.

Important Limitations

The researchers noted that factors like blood sugar control and body weight may still have influenced results slightly, as these couldn't be perfectly controlled for in the data.

References & Sources

Frequently asked questions

According to this large real-world study, no. Tirzepatide (Mounjaro) and semaglutide (Ozempic) showed very similar rates of serious gastrointestinal complications in type 2 diabetes patients.

Editorial note

This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 16, 2026 by the MDS Diabetes editorial team.

What to do next

📚

Ozempic, Mounjaro & Trulicity: Similar Stomach Side Effects